Clinical Trial Update: Study of the Absorption, Metabolism, and Route of Elimination of a Novel Class of Anti-HIV 1 Drugs (BMS-955176) in Humans. [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of the HIV-1 drug candidate BMS-955176 in humans has completed, assessing absorption, metabolism, and routes of elimination.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BMS-955176

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: COMPLETED